Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease Bristol Myers Squibb
Reflecting on CAR T for First Relapse in Multiple Myeloma Targeted Oncology
Subcutaneous Isatuximab Earns EU Approval in Multiple Myeloma CancerNetwork
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma OncLive
Teclistamab in Previously Treated Multiple Myeloma The ASCO Post
Mary Steinbach, DNP, APRN, on Measuring Treatment Response in Multiple Myeloma Cancer Nursing Today
Vij named inaugural Jeffrey S. and Prue H. Gershman Distinguished Professor WashU
‘Law & Order’ star Mariska Hargitay teams up with BMS to investigate multiple myeloma research in awareness campaign Fierce Pharma
The BioPharm Brief: Myeloma, Hemophilia, and KRAS BioPharm International
Mariska Hargitay investigates multiple myeloma research in BMS awareness campaign Medical Marketing and Media
Muhammad Bilal Abid: Balancing Accessibility and Cost-Efficiency in Multiple Myeloma Treatment Oncodaily
Equal Access to Modern Therapy May Help Eliminate Survival Differences in Multiple Myeloma Cleveland Clinic
Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple Myeloma Zacks Investment Research
Finding a Financial Lifeline During Cancer Cancer Health
Striving for a cure for multiple myeloma: What HCPs need to know Johnson & Johnson
Mariska Hargitay Talks Broadway Debut, Knicks, Multiple Myeloma TODAY.com
Machine Learning Model Outperforms Standard Risk Tools for Multiple Myeloma Cleveland Clinic
Mary Steinbach, DNP, APRN, on Supporting Shared Decision-Making in Multiple Myeloma Care Cancer Nursing Today
Hematologists Highlight Top Data From ASCO 2026 OncLive
Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026 OncLive
An Early Look at EHA 2026: 10 Key Studies Heading to Stockholm Targeted Oncology
Rewriting the Rules on Multiple Myeloma Resistance: Ajai Chari, MD AJMC
BCMA CAR T-Cell Therapy Improves OS Vs Teclistamab in Multiple Myeloma CancerNetwork
Mariska Hargitay Talks Broadway Debut, Knicks, Multiple Myeloma Yahoo
Mariska Hargitay Honors Dad Mickey In Bristol Myers' Myeloma Campaign 06/08/2026 MediaPost
The blood cancer that became solvable Works in Progress Magazine
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma Nature
Charting Progress, Changing Outcomes: The Evolution of Multiple Myeloma Care Sanofi
Teclistamab Improves Outcomes in Relapsed Multiple Myeloma University of Miami
A new immune strategy to keep multiple myeloma at bay Fred Hutchinson Cancer Center
Mariska Hargitay Partners With Bristol Myers Squibb for Multiple Myeloma Awareness Campaign geneonline.com
Edward Cliff: Does Cilta-Cel Have a Future in Myeloma? Oncodaily
What You Should Know About Smoldering Multiple Myeloma Health: Trusted and Empathetic Health and Wellness Information
Myeloma Paper of the Day, June 8th Suggested by Robert Orlowski Oncodaily
Bristol Myers Squibb launches myeloma awareness campaign Investing.com
Improving how multiple myeloma is understood and treated Mayo Clinic News Network
Al-Ola Abdallah: Simple Comparison of Teclistamab in Relapsed Multiple Myeloma Across Treatment Settings Oncodaily
Defining cure for multiple myeloma: Lu Anna’s story Roswell Park Comprehensive Cancer Center
Linvoseltamab May Improve Outcomes Vs Teclistamab in R/R Multiple Myeloma CancerNetwork
Multiple Myeloma: Diagnosis and Treatment American Academy of Family Physicians | AAFP